Herbamax Menstrual PMS Relief
Natural health product licensed in Canada
- Other names
- Herbamax Multi -symtom menstrual relief, Multi-symtom premenstrual & menstrual relief
- Licence holder
- 2106148 Ontario Ltd o/a Herbamax
- NPN or DIN-HM
- 80090560
- Status
- Active licence
- Licence date
- 12 February 2019
- Revision date
- 30 August 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Citrate de zinc | 3 milligramme | 9,000 µg |
| Curcuma longa Source : Rhizome Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 250 milligramme Potency : 3 % Curcuminoids | 25 milligramme | Not calculated |
| 3,3'-diindolylméthane Source : Brassica oleracea var. italica - plante entière | 25 milligramme | Not calculated |
| Vitex agnus-castus Source : Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 400 milligramme Potency : 0.5 % Agnuside | 40 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe féminin | Not specified | 3 Capsule | 1 day |
Uses authorised in Canada
Chaste bery tree is used in Herbal Medicine to relieve premenstrual symptoms , and as a hormone normalizer to help stabilize menstrual cycle irregularities. Help support /promote healthy estrogen metabolism and supports/promote a healthy estrogen metabolite ratio. Provide antioxidantas. Provides factors for PBA detoxifiation. Support the production of desirable estrogen metabolism. Help support estrogen metabolism by promoting a higher 2 hydroxysterone to 16- hydroxyesterone rratio. Helps reduce the severity and duration of symptoms associated with cyclical mastalgia (recurrent breast pain).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are pregnant, breastfeeding, or attempting to conceive unless you have consulted with a healthcare practitioner/healthcare provider/healthcare professional/doctor/physician.
Source
Official Health Canada record, licence 80090560
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging